Qu Biologics Launches Phase 2a Clinical Trial for Non-small Cell Lung Cancer (NSCLC)
20 janv. 2015 10h00 HE
|
Qu Biologics;BC Cancer Agency
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione to IBD Advisory Team
04 déc. 2014 10h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics' Crohn's Disease Clinical Trial Completes Independent Safety Review
29 oct. 2014 09h30 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 29, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Closes Oversubscribed Private Funding Round of CDN$5.1 Million
17 sept. 2014 10h05 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Appoints Dr. Bob Cory as Vice President, Business Development
17 juin 2014 10h30 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived from Viruses for Treating a Range of Cancers
04 juin 2014 10h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Colon Cancer
20 mai 2014 13h07 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 20, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics to Present Crohn's Disease Compassionate Use Results at Digestive Diseases Week Conference
28 avr. 2014 14h45 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants
20 févr. 2014 20h49 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 20, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants
18 févr. 2014 09h00 HE
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 18, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...